SK99894A3 - Pyrazolopyrimidine derivatives, method of their preparation pharmaceutical agent and use - Google Patents

Pyrazolopyrimidine derivatives, method of their preparation pharmaceutical agent and use Download PDF

Info

Publication number
SK99894A3
SK99894A3 SK998-94A SK99894A SK99894A3 SK 99894 A3 SK99894 A3 SK 99894A3 SK 99894 A SK99894 A SK 99894A SK 99894 A3 SK99894 A3 SK 99894A3
Authority
SK
Slovakia
Prior art keywords
group
formula
compound
lower alkyl
carbon atoms
Prior art date
Application number
SK998-94A
Other languages
English (en)
Slovak (sk)
Inventor
Nicole Bru-Magniez
Timur Gungor
Jean-Marie Teulon
Original Assignee
Upsa Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9202109A external-priority patent/FR2687676B1/fr
Application filed by Upsa Sa Lab filed Critical Upsa Sa Lab
Publication of SK99894A3 publication Critical patent/SK99894A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK998-94A 1992-02-24 1993-02-18 Pyrazolopyrimidine derivatives, method of their preparation pharmaceutical agent and use SK99894A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9202109A FR2687676B1 (fr) 1992-02-24 1992-02-24 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR9205417A FR2687677B1 (fr) 1992-02-24 1992-04-30 Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
PCT/FR1993/000160 WO1993017023A1 (fr) 1992-02-24 1993-02-18 Derives de pyrazolopyrimidines antagonistes des recepteurs a l'angiotensine ii

Publications (1)

Publication Number Publication Date
SK99894A3 true SK99894A3 (en) 1995-04-12

Family

ID=26229283

Family Applications (2)

Application Number Title Priority Date Filing Date
SK998-94A SK99894A3 (en) 1992-02-24 1993-02-18 Pyrazolopyrimidine derivatives, method of their preparation pharmaceutical agent and use
SK997-94A SK280343B6 (sk) 1992-02-24 1993-02-18 Triazolopyrimidínové deriváty ako antigonisty rece

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK997-94A SK280343B6 (sk) 1992-02-24 1993-02-18 Triazolopyrimidínové deriváty ako antigonisty rece

Country Status (19)

Country Link
EP (2) EP0628046B1 (enExample)
JP (2) JP3372040B2 (enExample)
KR (2) KR100272922B1 (enExample)
AT (1) ATE179979T1 (enExample)
AU (2) AU668139B2 (enExample)
CA (2) CA2128876C (enExample)
CZ (2) CZ204594A3 (enExample)
DE (1) DE69324910T2 (enExample)
EE (2) EE03046B1 (enExample)
ES (1) ES2133390T3 (enExample)
FI (2) FI943808L (enExample)
FR (1) FR2687677B1 (enExample)
HU (2) HU220392B (enExample)
MD (2) MD553G2 (enExample)
NZ (2) NZ249509A (enExample)
RU (1) RU2116308C1 (enExample)
SK (2) SK99894A3 (enExample)
TW (2) TW221438B (enExample)
WO (2) WO1993017023A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
TWI334868B (en) * 2003-06-03 2010-12-21 Nippon Kayaku Kk [1,2,4] triazoro [1,5-a] pyrimidine-2-ylurea derivative and use thereof
JP2008538759A (ja) * 2005-04-25 2008-11-06 ビーエーエスエフ ソシエタス・ヨーロピア 新規アゾロピリミジンである５−アルキル−６−フェニルアルキル−７−アミノアゾロピリミジンの使用、その製造方法、およびそれを含有する組成物
WO2008003753A1 (en) * 2006-07-07 2008-01-10 Biovitrum Ab (Publ) Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity
DE102006039255A1 (de) * 2006-08-17 2008-02-21 Bayer Cropscience Ag Insektizide heterocyclische Carbonsäurederivate
ES2433225T3 (es) * 2009-01-30 2013-12-10 Takeda Pharmaceutical Company Limited Compuesto con anillos condensados y uso del mismo
CN103328479A (zh) 2010-09-27 2013-09-25 普罗克斯马根有限公司 7-羟基-吡唑并[1，5-a]嘧啶化合物及其作为ccr2受体拮抗剂的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
WO1991015209A1 (en) * 1990-03-30 1991-10-17 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
FR2678618B1 (fr) * 1991-07-05 1993-11-05 Upsa Laboratoires Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
RU2116308C1 (ru) 1998-07-27
EE03045B1 (et) 1997-10-15
KR950700303A (ko) 1995-01-16
NZ249509A (en) 1996-06-25
DE69324910D1 (de) 1999-06-17
WO1993017024A1 (fr) 1993-09-02
JP3372040B2 (ja) 2003-01-27
MD553F1 (en) 1996-05-31
EE03046B1 (et) 1997-10-15
SK280343B6 (sk) 1999-12-10
CZ204494A3 (en) 1994-12-15
FI943807A7 (fi) 1994-10-24
ATE179979T1 (de) 1999-05-15
RU94040854A (ru) 1996-08-10
FR2687677A1 (fr) 1993-08-27
FI943807L (fi) 1994-10-24
CA2128871A1 (en) 1993-09-02
FI943807A0 (fi) 1994-08-19
AU3635893A (en) 1993-09-13
FI943808A0 (fi) 1994-08-19
JPH07504177A (ja) 1995-05-11
SK99794A3 (en) 1995-04-12
MD553G2 (ro) 1996-12-31
CA2128876C (en) 2004-02-03
AU3635793A (en) 1993-09-13
NZ249508A (en) 1996-07-26
EP0628045A1 (fr) 1994-12-14
CA2128876A1 (en) 1993-09-02
CZ282075B6 (cs) 1997-05-14
DE69324910T2 (de) 1999-10-21
HUT70953A (en) 1995-11-28
AU668544B2 (en) 1996-05-09
KR100272922B1 (ko) 2001-02-01
HUT70949A (en) 1995-11-28
MD554F1 (en) 1996-05-31
FI943808A7 (fi) 1994-10-24
TW222275B (enExample) 1994-04-11
KR950700302A (ko) 1995-01-16
AU668139B2 (en) 1996-04-26
FI943808L (fi) 1994-10-24
FR2687677B1 (fr) 1996-10-11
EP0628046A1 (fr) 1994-12-14
ES2133390T3 (es) 1999-09-16
MD554G2 (ro) 1997-01-31
HU9402429D0 (en) 1994-10-28
JPH07504178A (ja) 1995-05-11
CZ204594A3 (en) 1994-12-15
HU220392B (hu) 2002-01-28
EP0628046B1 (fr) 1999-05-12
WO1993017023A1 (fr) 1993-09-02
TW221438B (enExample) 1994-03-01
HU9402430D0 (en) 1994-10-28

Similar Documents

Publication Publication Date Title
AU708750B2 (en) 6-substituted pyrazolo {3,4-d} pyrimidin-4-ones and compositions and methods of use thereof
KR900007780B1 (ko) 축합된 피롤리논 유도체의 제조방법
US5231094A (en) Triazolopyrimidines which are angiotensin II receptor antagonists and pharmaceutical compositions in which they are present
KR100224135B1 (ko) 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
JP3140566B2 (ja) アンギオテンシンｉｉリセプタ拮抗剤である新規なトリアゾロピリミジン誘導体、その製造方法、およびそれを含有する医薬組成物
JPH06211846A (ja) ベンゾフラン誘導体
JP2753659B2 (ja) ピラゾール誘導体
CA1271751A (en) Dihydroimidazo[1,2-a]pyrimidine derivatives
SK99794A3 (en) Triazolopyrimidine derivatives as antiotensin ii receptor antagonists, method of their preparation, pharmaceutical agent and use
US5387747A (en) Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
US5389632A (en) Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
JP2750869B2 (ja) 三環式縮合ピリミジン誘導体
CS248720B2 (en) Production method of quinolines
JPS59141580A (ja) インド−ル誘導体
EP0118205B1 (en) (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h-pyrazol-4-yl)(aryl)methanones and processes for their production
JP3059572B2 (ja) ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを有効成分とする高血圧治療剤
WO2012127472A1 (en) Process and intermediates for the preparation of preladenant and related compounds
JPS61233688A (ja) ベンゼン縮合複素環化合物
PL90417B1 (en) New indazole derivatives,their production and pharmaceutical compositions containing them[il44556d0]
WO1993024487A1 (en) Nitrogen containing heterocyclic compounds as angiotensin-ii-antagonists